{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:07:58Z","timestamp":1756382878808},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1007\/s10165-012-0756-0","type":"journal-article","created":{"date-parts":[[2012,9,16]],"date-time":"2012-09-16T09:16:18Z","timestamp":1347786978000},"page":"872-883","source":"Crossref","is-referenced-by-count":2,"title":["Marked increase in serum KL-6 and surfactant protein\u00a0D levels during the first 4\u00a0weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis\/dermatomyositis"],"prefix":"10.1093","volume":"23","author":[{"given":"Satoko","family":"Arai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Kurasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reika","family":"Maezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Owada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harutsugu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,9,17]]},"reference":[{"key":"756_CR1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/art.10794","volume":"47","author":"I Marie","year":"2002","unstructured":"Marie I, Hachulla E, Ch\u00e9rin P, Dominique S, Hatron PY, Hellot MF, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum. 2002;47:614\u201322.","journal-title":"Arthritis Rheum"},{"key":"756_CR2","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/01.bor.0000179949.65895.53","volume":"17","author":"M Fathi","year":"2005","unstructured":"Fathi M, Lundberg IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2005;17:701\u20136.","journal-title":"Curr Opin Rheumatol"},{"key":"756_CR3","first-page":"1527","volume":"26","author":"Y Nawata","year":"1999","unstructured":"Nawata Y, Kurasawa K, Takabayashi K, Miike S, Watanabe N, Hiraguri M, et al. Corticosteroid resistant interstitial pneumonitis in dermatomyositis\/polymyositis: prediction and treatment with cyclosporine. J Rheumatol. 1999;26:1527\u201333.","journal-title":"J Rheumatol"},{"key":"756_CR4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002281-200011000-00005","volume":"12","author":"M Hirakata","year":"2000","unstructured":"Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000;12:501\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"756_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/ard.2003.006122","volume":"63","author":"M Fathi","year":"2004","unstructured":"Fathi M, Dastmalchi M, Rasmussen E, Lundberg IE, Tornling G. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis. 2004;63:297\u2013301.","journal-title":"Ann Rheum Dis"},{"key":"756_CR6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3899\/jrheum.101002","volume":"38","author":"Y Yamasaki","year":"2011","unstructured":"Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, et al. Long term survival and associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis: experience in a single institute in Japan. J Rheumatol. 2011;38:1636\u201343.","journal-title":"J Rheumatol"},{"key":"756_CR7","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1093\/rheumatology\/keh723","volume":"44","author":"EH Kang","year":"2005","unstructured":"Kang EH, Lee EB, Shin KC, Im CH, Chung DH, Han SK, Song YW. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology (Oxford). 2005;44:1282\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"756_CR8","first-page":"1719","volume":"32","author":"H Kameda","year":"2005","unstructured":"Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute\/subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol. 2005;32:1719\u201326.","journal-title":"J Rheumatol"},{"key":"756_CR9","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1378\/chest.08-2740","volume":"136","author":"H Mukae","year":"2009","unstructured":"Mukae H, Ishimoto H, Sakamoto N, Hara S, Kakugawa T, Nakayama S, et al. Clinical differences between interstitial lung disease associated with clinically amyopathicdermatomyositis and classic dermatomyositis. Chest. 2009;136:1341\u20137.","journal-title":"Chest"},{"key":"756_CR10","first-page":"58","volume":"32","author":"T Fujisawa","year":"2005","unstructured":"Fujisawa T, Suda T, Nakamura Y, Enomoto N, Ide K, Toyoshima M, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol. 2005;32:58\u201364.","journal-title":"J Rheumatol"},{"key":"756_CR11","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2249.2002.01933.x","volume":"129","author":"K Kurasawa","year":"2002","unstructured":"Kurasawa K, Nawata Y, Takabayashi K, Kumano K, Kita Y, Takiguchi Y, et al. Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis\/polymyositis. Clin Exp Immunol. 2002;129:541\u20138.","journal-title":"Clin Exp Immunol"},{"key":"756_CR12","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/rheumatology\/keq073","volume":"49","author":"T Gono","year":"2010","unstructured":"Gono T, Kawaguchi Y, Hara M, Masuda I, Katsumata Y, Shinozaki M, et al. Increased ferritin predicts development and severity of acute interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010;49:1354\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"756_CR13","doi-asserted-by":"crossref","unstructured":"Nukiwa T. The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes. In: du Bois RM, Richeldi L, editors. Interstitial lung diseases. European Respiratory Society Monograph, vol 46. 2009. p. 47\u201366.","DOI":"10.1183\/1025448x.00046004"},{"key":"756_CR14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1378\/chest.96.1.68","volume":"96","author":"N Kohno","year":"1989","unstructured":"Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest. 1989;96:68\u201373.","journal-title":"Chest"},{"key":"756_CR15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.159.2.9806064","volume":"159","author":"C Hermans","year":"1999","unstructured":"Hermans C, Bernard A. Lung epithelium-specific proteins: characteristics and potential applications as markers. Am J Respir Crit Care Med. 1999;159:646\u201378.","journal-title":"Am J Respir Crit Care Med"},{"key":"756_CR16","doi-asserted-by":"crossref","first-page":"L1088","DOI":"10.1152\/ajplung.00420.2002","volume":"286","author":"A Ishizaka","year":"2004","unstructured":"Ishizaka A, Matsuda T, Albertine KH, Koh H, Tasaka S, Hasegawa N, et al. Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol. 2004;286:L1088\u201394.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"756_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1378\/chest.108.2.311","volume":"108","author":"J Kobayashi","year":"1995","unstructured":"Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest. 1995;108:311\u20135.","journal-title":"Chest"},{"key":"756_CR18","first-page":"1164","volume":"27","author":"H Nakajima","year":"2000","unstructured":"Nakajima H, Harigai M, Hara M, Hakoda M, Tokuda H, Sakai F, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol. 2000;27:1164\u201370.","journal-title":"J Rheumatol"},{"key":"756_CR19","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1164\/ajrccm.160.6.9901117","volume":"160","author":"KE Greene","year":"1999","unstructured":"Greene KE, Wright JR, Steinberg KP, Ruzinski JT, Caldwell E, Wong WB, et al. Serial changes in surfactant- associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med. 1999;160:1843\u201350.","journal-title":"Am J Respir Crit Care Med"},{"key":"756_CR20","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1164\/ajrccm.152.6.8520747","volume":"152","author":"Y Honda","year":"1995","unstructured":"Honda Y, Kuroki Y, Matsuura E, Nagae H, Takahashi H, Akino T, Abe S. Pulmonary surfactant protein\u00a0D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med. 1995;152:1860\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"756_CR21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1164\/ajrccm.162.3.9910080","volume":"162","author":"H Takahashi","year":"2000","unstructured":"Takahashi H, Fujishima T, Koba H, Murakami S, Kurokawa K, Shibuya Y, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med. 2000;162:1109\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"756_CR22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med. 1975;292:344\u20137.","journal-title":"N Engl J Med"},{"key":"756_CR23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46:626\u201336.","journal-title":"J Am Acad Dermatol"},{"key":"756_CR24","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","volume":"60","author":"S Sato","year":"2009","unstructured":"Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Kuwana M. RNA helicase encoded by melanoma diff erentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. Arthritis Rheum. 2009;60:2193\u2013200.","journal-title":"Arthritis Rheum"},{"key":"756_CR25","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1378\/chest.123.4.1096","volume":"123","author":"H Arakawa","year":"2003","unstructured":"Arakawa H, Yamada H, Kurihara Y, Nakajima Y, Takeda A, Fukushima Y, Fujioka M. Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis: serial high-resolution CT findings and functional correlation. Chest. 2003;123:1096\u2013103.","journal-title":"Chest"},{"key":"756_CR26","first-page":"258","volume":"44","author":"GC Ooi","year":"2003","unstructured":"Ooi GC, Mok MY, Tsang KW, Wong Y, Khong PL, Fung PC, et al. Interstitial lung disease in systemic sclerosis. Acta Radiol. 2003;44:258\u201364.","journal-title":"Acta Radiol"},{"key":"756_CR27","doi-asserted-by":"crossref","unstructured":"Kubo M, Ihn H, Yamane K, Kikuchi K, Yazawa N, Soma Y, Tamaki K. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology (Oxford). 2000; 39: 632\u20136.","DOI":"10.1093\/rheumatology\/39.6.632"},{"key":"756_CR28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.59.4.257","volume":"59","author":"S Bandoh","year":"2000","unstructured":"Bandoh S, Fujita J, Ohtsuki Y, Ueda Y, Hojo S, Tokuda M, et al. Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis\/dermatomyositis. Ann Rheum Dis. 2000;59:257\u201362.","journal-title":"Ann Rheum Dis"},{"key":"756_CR29","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/rheumatology\/41.11.1268","volume":"41","author":"H Ihn","year":"2002","unstructured":"Ihn H, Asano Y, Kubo M, Yamane K, Jinnin M, Yazawa N, et al. Clinical significance of serum surfactant protein\u00a0D (SP-D) in patients with polymyositis\/dermatomyositis: correlation with interstitial lung disease. Rheumatology (Oxford). 2002;41:1268\u201372.","journal-title":"Rheumatology (Oxford)"},{"key":"756_CR30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00795-007-0360-0","volume":"40","author":"Y Ohtsuki","year":"2007","unstructured":"Ohtsuki Y, Nakanishi N, Fujita J, Yoshinouchi T, Kobayashi M, Ueda N, et al. Immunohistochemical distribution of SP-D, compared with that of SP-A and KL-6, in interstitial pneumonias. Med Mol Morphol. 2007;40:163\u20137.","journal-title":"Med Mol Morphol"},{"key":"756_CR31","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1440-1843.2006.00809.x","volume":"11","author":"H Takahashi","year":"2006","unstructured":"Takahashi H, Shiratori M, Kanai A, Chiba H, Kuroki Y, Abe S. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology. 2006;11:S51\u20134.","journal-title":"Respirology"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10165-012-0756-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:28:09Z","timestamp":1646843289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-012-0756-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,17]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s10165-012-0756-0","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,17]]}}}